Trials / Completed
CompletedNCT01949428
House Dust Mite Observational Study
A Field Study to Observe Symptom Scores and Allergy Medication Usage in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (actual)
- Sponsor
- Circassia Limited · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
A Field Study to Observe Symptom Scores and Allergy Medication Usage in Subjects with a History of House Dust Mite-Induced Rhinoconjunctivitis
Detailed description
House Dust Mites (HDM) are arachnids that infest bedding, carpet, upholstered furniture and fabric. Like many other allergens, exposure to HDMA in sensitised patients is associated with poorer lung function, greater medication requirements and more asthma symptoms as well as chronic rhinosinusitis symptoms. In contrast to other allergens, there is evidence that HDMA leads to the development of asthma, in addition to exacerbating pre-existing asthma in HDM-sensitised patients. The proposed observational study is designed to gather information on subjects with HDM-related rhinoconjunctivitis.
Conditions
Timeline
- Start date
- 2013-09-01
- Primary completion
- 2014-03-01
- Completion
- 2014-03-01
- First posted
- 2013-09-24
- Last updated
- 2014-05-15
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT01949428. Inclusion in this directory is not an endorsement.